Share to
  • Email
  • Facebook
  • X
  • Bluesky
  • Instagram
  • LinkedIn
Share to
  • Email
  • Facebook
  • X
  • Bluesky
  • Instagram
  • LinkedIn
Back to Test Catalogue
Test ID: VGKC S

Voltage-Gated Potassium Channel (VGKC) Antibodies, Serum

Test Overview

Clinical Utility

Voltage-Gated Potassium Channel (VGKC) Antibody – Limbic encephalitis (LE) is a paraneoplastic neurological syndrome often associated with small cell lung carcinoma and more rarely with testicular, breast, and other tumors. Clinical hallmarks of paraneoplastic limbic encephalitis are changing mental status, short-term memory impairment, seizures, confusion, and behavioral changes. Hu antibody-negative LE patients usually do not develop symptoms beyond the limbic system and appear to improve more often after treatment of the cancer than those who have Hu antibodies, suggesting that the pathogenesis of the LE in both groups could be different. Recent studies have detected antibodies to voltage-gated potassium channels (VGKC) in patients with LE, with and without associated tumors. Neurological symptoms were found to improve with a reduction of VGKC antibody levels.

Method

Radioimmunoassay (RIA)

Result Included

Voltage-Gated Potassium Channel (VGKC) Antibodies

Specimen

Specimen Type

Serum

Volume

Sample Volume

1.0 mL

Minimum Volume

0.5 mL

Collection & Handling

Handling Information

Store and send frozen

Stability

Ambient Refrigerated Frozen
48 hours 48 hours 73 days

Performance & Interpretation

Turnaround Time

14 days

Results

Name
Units
Reference Range
Conversion
  1. Voltage-Gated Potassium Channel (VGKC) Antibodies
    pmol/L
    <80

Referral Location

Out-of-Country

Interface & Setup

HL7 Interface Codes

Order Code Result Name Result Codes Units
VGKC S VOLTAGE GATED POTASSIUM CHANNEL (VGKC) AB 63125 pmol/L

Test Version

Last Updated

2019-11-28